Ranked #149 of 397 · scores higher than 63% of peers · safety percentile 65
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)
44 peers with a safety percentile of 60–69, including ZYME · Click a bar to see the companies
Why “Moderate relative risk”?
The measures below combine into a safety percentile of 65 among Healthcare companies. It is relative: 67 or more is lower relative risk, 33–66 moderate, below 33 higher.
A mix: stronger current ratio, but weaker beta than most Healthcare peers.
▼a share price that has swung more with the market: weaker than 82% of peers. Beta: 1.19 vs peer median 0.63
●Debt / equity is close to the peer norm. Debt / equity: 0.20× vs peer median 0.22×
▲more short-term assets to cover bills due within a year: stronger than 79% of peers. Current ratio: 6.32× vs peer median 2.59×
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
Metric by metric
Position: dot = ZYME, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
